ライフサイエンスコーパス: blood sample

1 DXA and quantified metabolic parameters in a blood sample.

2 ratory indicators, were measured in a venous blood sample.

3 rs of bacteria need to be found in a 1-10 mL blood sample.

4 R assay conducted on DNA isolated from whole blood samples.

5 e into the GenX Exposure Study and collected blood samples.

6 tection in spiked plasma as well as in whole blood samples.

7 rtle (Caretta caretta) via analysis of small blood samples.

8 ecule) antibodies to isolate CTCs from human blood samples.

9 , were twice as high as in paired peripheral blood samples.

10 antitative detection of mtDNA copy number in blood samples.

11 targeted lipidomics was undertaken using all blood samples.

12 ed to reference plasma and DPS from the same blood samples.

13 parum lactate dehydrogenase (PfLDH) in whole blood samples.

14 vated in all human cancer versus all control blood samples.

15 ssion compared with non-remission from whole blood samples.

16 nia, but all of them did so using peripheral blood samples.

17 e detection of protein biomarkers from whole blood samples.

18 ta and Candida albicans) from Candida-spiked blood samples.

19 nriched clonotypes was tracked across serial blood samples.

20 study inclusion, and they were asked to give blood samples.

21 matory marker levels were measured in venous blood samples.

22 We also collected blood samples.

23 from the undiluted and untreated buffy coat blood samples.

24 g borderline changes) in 614 of 1763 (34.8%) blood samples.

25 DNA was extracted and genotyped from blood samples.

26 , and 28 biomarkers were analysed in patient blood samples.

27 lmalonic acid (MMA) were assessed in fasting blood samples.

28 ivity before detection by routine peripheral blood sampling.

29 light exposure at night using high-frequency blood sampling.

30 sive, easy-to-use, continuous alternative to blood sampling.

31 dard for the measurement of lactate requires blood sampling.

32 ification of tau deposits, avoiding arterial blood sampling.

33 ocatheter aspiration of 3 different arterial blood samples: (1) within the core of the occluded vascu

34 tom onset (median time from symptom onset to blood sampling = 3.3 hours; interquartile range [IQR] =

35 owed dysregulation in both tissue as well as blood samples, along with progressive decrease in expres

36 d lead concentrations were measured in whole blood samples among 1,548 participants (91% of cohort).

37 39 maternal blood specimens and 100-201 cord blood samples analyzed.

38 nanocages were evaluated using HNC patients' blood sample and compared for the CTC capturing efficien

39 Obtaining plasma from a blood sample and preparing it for subsequent analysis is

40 rformed on maternal DNA from both peripheral blood sample and urine-derived podocyte-lineage cells un

41 sequencing in a series of 14 runs across 43 blood samples and 504 publically available NGS datasets.

42 Platelets were isolated from blood samples and allowed to spread on coverslips in the

43 he concomitant biopsy in 188 of 1763 (10.7%) blood samples and any rejection (including borderline ch

44 easured in a central laboratory from fasting blood samples and categorized as <=0.5 nmol/L, >0.5-1.0

45 rectly in circulation without having to draw blood samples and correlate the measurement with a phant

46 rotein measurements from anti-dsDNA(pos) SLE blood samples and derived an IFN protein signature (IFNP

47 c flow cytometry to analyze whole peripheral blood samples and determined SARS-CoV-2-specific antibod

48 Blood samples and fecal samples were collected at interv

49 jection and treatment resistance, peripheral blood samples and intestinal allograft biopsies from 51

50 ak exercise from femoral arterial and venous blood samples and leg blood flow (by thermodilution) in

51 tokines in serum and in LPS-stimulated whole blood samples and leukocyte membrane fatty acid profiles

52 nset of clinical signs and less viral DNA in blood samples and nasal secretions was observed in some

53 was assessed in all patients with available blood samples and safety was assessed in all participant

54 valuating library performance across 6 human blood samples and the other examining library reproducib

55 Venous blood samples and urine were collected for pharmacokinet

56 as estimated with activity measurements from blood samples and with whole-body measurements that were

57 macaques were acquired for 2 h with arterial blood sampling and metabolite analysis to measure the in

58 Arterial blood sampling and metabolite analysis were conducted.

59 Blood sampling and spirometry were performed before and

60 off point that is specific for the method of blood sampling and the method of Hb measurement.

61 Metagenomics confirmed M. smithii in five blood samples, and M. smithii was isolated via culture i

62 lar biology analyses on brain and peripheral blood samples, and pharmacological investigations were p

63 king and alcohol intake, gestational week of blood sampling, and maternal history of miscarriage.

64 ranscription has been measured in peripheral blood samples as a candidate biomarker of inflammation a

65 tained similar percentage of sickle cells in blood samples as analyzed by conventional method (standa

66 One hour later, jugular vein blood samples as well as intestinal samples were collect

67 g myeloid cells and CD4(+) T cells from cord blood samples, as well as in response to lipopolysacchar

68 y center who provided one spot urine and one blood sample at enrollment (2005-2015).

69 -methylation associations in human brain and blood samples at a cell type-specific level.

70 Paired blood samples at baseline and after 12 months of treatme

71 240 min postingestion with additional venous blood sampling at 5, 10, 15, and 30 min postingestion.

72 T, (18)F-FDG PET/CT, and complete peripheral blood sampling at baseline before ICI treatment.

73 2008, and had a pre-HSCT recipient or donor blood sample available.

74 mia after stopping ART), who provided serial blood samples before death and their bodies for rapid au

75 otional face-processing task during fMRI and blood sampling before and after their first IFN-alpha (4

76 s of pathological proteins to be measured in blood samples, but research has been predominantly focus

77 roportions from gene expression data of bulk blood samples, but their performance when applied to bra

78 CD8(+) T cells were isolated from blood samples by magnetic bead sorting at the point of d

79 or label-free detection of CTCs from patient blood samples, by taking advantage of data analysis of b

80 cted from mutational screening on peripheral blood samples, cases in kidney-confined mosaic form have

81 nherent variation of R(2) values of clinical blood samples, caused by many physiological and genotypi

82 chedule, had at least one measured post-dose blood sample collected, and were not diagnosed with HIV

83 The biomarkers were measured in fasting blood samples collected at 5-13, 20-26, and 30-36 weeks

84 Performance of the test in capillary blood samples collected by finger-prick was noninferior

85 cohort on persons 35 to 79 years old who had blood samples collected from 1985 through 1996.

86 This protocol was then applied to blood samples collected from human volunteers (n = 6, he

87 tion on mean DTP antibody titres measured in blood samples collected from infants at 12 weeks (n = 71

88 and training cohort consisted of peripheral blood samples collected from patients treated at the Uni

89 struct absorbed radiation dose in peripheral blood samples collected from potentially exposed individ

90 RNA was isolated from the blood samples collected from the thermoneutral and heat

91 based diagnosis of dengue virus in clinical blood samples collected from total of 102 subjects.

92 hether peripheral immune factors measured in blood samples collected in an emergency department immed

93 rmonal profiles were determined from fasting blood samples collected prior to intervention.

94 nction testing, chest computed tomography, a blood sample collection for immunophenotyping, telomere

95 ture inoculation occurred on the same day as blood sample collection.

96 ral advantages, including minimal amounts of blood, sample collection, simplified storage and shippin

97 es concerning indwelling vascular catheters, blood sampling, combination antiseptics or sequential ap

98 ls detected in microscopic images of patient blood samples containing white blood cells and CTCs.

99 s in the descending aorta were compared with blood samples counted on a calibrated gamma-counter.

100 col differed by an average of around 5% from blood samples counted on a calibrated gamma-counter.

101 and assess its performance with unprocessed blood samples (dbRT-RPA).

102 Using human blood samples derived before the SARS-CoV-2 virus was di

103 drug was determined at months 1 and 5 using blood samples drawn 2 hours postdose.

104 Blood samples drawn at ages 4 to 6 (n = 5989), 8 to 10 (

105 etects a prolonged clotting time in clinical blood samples drawn from pediatric patients on extracorp

106 asma Separation membrane to threat the whole blood sample, filter paper to load the reagents needed f

107 ndial MRI scans, symptom questionnaires, and blood sampling following a 400-g soup meal (204 kcal).

108 are antibody test, and, if agreed, donated a blood sample for additional testing with a chemiluminesc

109 device to purify Candida species from whole blood sample for enhanced molecular diagnosis of bloodst

110 Blood samples for 25(OH)VD and the procollagen type III

111 ontrols answered questionnaires and provided blood samples for assay of pepsinogens.

112 Fasting blood samples for cardiac stress markers were obtained b

113 -thickness burns or delayed healing provided blood samples for genotyping and self-reported itch scor

114 n alcohol cue-reactivity procedure, and gave blood samples for PK/PD testing.

115 bility in collection and processing of human blood samples for research remains a challenge.

116 rt Expenditure for Rewards Task and provided blood samples for the assessment of C-reactive protein (

117 erates using the analysed fluid, mimicking a blood sample, for early stage detection of HIV-1 infecti

118 F is routinely determined with radio-HPLC of blood sampled frequently during the PET experiment.

119 h the top-ranked genes were then measured in blood sampled from a diverse cohort of patients diagnose

120 We obtained peripheral blood samples from 112 children with a new diagnosis of

121 ssion on immune cells from tumor and matched blood samples from 12 patients with resectable PDAC.

122 ntiaggregant properties of HDL, we collected blood samples from 15 healthy volunteers, 25 patients on

123 We drew blood samples from 17 heifers on the day of artificial i

124 iratory tract specimens as well as fecal and blood samples from 180 patients with confirmed infection

125 Gastric biopsy specimens and blood samples from 185 subjects (patients with EG, n = 7

126 We obtained blood samples from 185 young women (average age 21.2) in

127 ram of blood lead testing in Arizona, condor blood samples from 2008 to 2018 were screened for haemos

128 ic immune response to stroke in longitudinal blood samples from 24 patients over the course of 1 year

129 Preoperative blood samples from 242 patients between September 2009 a

130 differentiated EM (TEMRA) CD8(+) T cells-in blood samples from 284 kidney transplant recipients recr

131 We took blood samples from 30 healthy young male volunteers befo

132 yzed the untargeted metabolome of 784 weekly blood samples from 30 pregnant women.

133 thods: RNA sequencing was performed on whole-blood samples from 359 patients with idiopathic, heritab

134 ntibodies from paired adenoid and peripheral blood samples from 4 young children.

135 We also sequenced DNA from blood samples from 40 healthy control individuals.

136 t its implementation, we analyzed peripheral blood samples from 400 HIV-1(+) adults on ART from sever

137 postmortem hippocampal formation and matched blood samples from 52 patients with AD and 11 individual

138 Comprehensive flow cytometry of whole blood samples from 54 COVID-19 patients reveals a dramat

139 ted the timing of p-tau181 changes using 153 blood samples from 70 individuals in a longitudinal stud

140 OV) and other potential pathogens from whole-blood samples from 70 patients with suspected Ebola hemo

141 Archived tissues and stored peripheral blood samples from 81 patients who underwent HCC resecti

142 We analyzed waste blood samples from a community clinic from 15,551 adults

143 Blood samples from adult patients hospitalized with COVI

144 plasma immune biomarkers were carried out on blood samples from all participants.

145 Blood samples from all patients were collected three tim

146 ared metal levels in prospectively collected blood samples from ALS patients and controls, to explore

147 This study analysed fasting (8 h) blood samples from an obese, normoglycemic cohort and an

148 performed whole-exome sequencing analyses of blood samples from an unselected cohort of 1005 children

149 ved in 616 matched normal tissues and in 249 blood samples from children without cancer, respectively

150 clones at autopsy were present in tissue and blood samples from earlier time points.

151 Moreover, SECH clears HIV-1 in blood samples from HIV-1-infected patients.

152 First, blood samples from HIV-positive and a comparison group o

153 red from single and longitudinally collected blood samples from immunocompromised children to show th

154 an Hormone (AMH) can be reliably detected in blood samples from neonate male turtles but not females

155 Blood samples from NSML patients also showed a shear str

156 nts in cardiac tissue samples from GCM or in blood samples from other types of myocarditis.

157 Blood samples from patients enrolled in a previously pub

158 Whole blood samples from patients treated for symptomatic CAD

159 In an analysis of cell-free DNA in blood samples from patients who underwent chemoradiother

160 Multiparameter analysis using blood samples from patients with (anti)coagulation disor

161 mune cell populations specific to mucosa and blood samples from patients with active or inactive CD a

162 stigate the effects of these minor variants, blood samples from patients with acute EVD were deeply s

163 can detect N-acetylasparate in finger-prick blood samples from patients with TBI, and that the bioma

164 on and T-cell proliferation were tested with blood samples from selected patients.

165 ue samples from 27 cancer sites and in 7,149 blood samples from The Cancer Genome Atlas.

166 c obstructive pulmonary disease (COPD) using blood samples from the COPDGene enrollment visit.

167 ut a validation study using paired DBS-whole blood samples from venous and capillary sources from 49

168 ical manufacturing facility were detected in blood samples from Wilmington, North Carolina, residents

169 sample had a positive test result but second blood sample had a negative result for tTGA were older,

170 Interestingly, adults whose first blood sample had a positive test result but second blood

171 iles for cellular heterogeneity within whole blood samples had a detrimental effect on the classifica

172 The blood samples had been collected at 2 time points (media

173 ation of MCF-7 tumor cells from spiked human blood samples has also been demonstrated.

174 ation of circulating tumor cells (CTCs) from blood samples has important prognostic and therapeutic i

175 Monitoring CTCs in blood samples has increased exponentially over the past

176 Presently, blood samples have been collected from over 800,000 enro

177 Cell type-specific analyses in blood samples identified methylome-wide significant asso

178 e telomere length in pretransplant recipient blood samples in 1514 MDS patients and evaluated the ass

179 ers and 32 healthy volunteers and peripheral blood samples in 33 SSD and 31 healthy volunteers.

180 atory cytokines IL-4 and IL-10 in tonsil and blood samples in RAT, PTA, and samples without inflammat

181 ractical application in the testing of whole blood samples in the point-of-care settings.

182 he uric acid concentration in clinical human blood samples, indicating a great potential of CaT-SMelo

183 infections retrospectively if a convalescent blood sample is not obtained also impairs epidemiologic

184 sensor for lymphoma cancer cells in clinical blood samples is consistent with that of commercial flow

185 number of CTCs in standard 10-mL peripheral blood samples limits their clinical utility.

186 red to that in plasma obtained from the same blood sample, looking at Nf-L discriminatory power in th

187 Blood samples (n = 101) were collected from 57 COVID-19

188 stmortem brain (n = 206) and 1 collection of blood samples (N = 1132) of MDD cases and controls, we u

189 (uRT-qPCR) using nucleic acid extracts from blood samples (n = 114) obtained after standardized cont

190 A subset of blood samples (n = 1154) was laboratory tested for HRP2

191 ed mean difference across 4 studies of whole-blood samples (n = 1567 cases, n = 954 controls), 343 ge

192 and 46 healthy control subjects), and whole blood samples (n = 498) from the Unbiased Biomarkers for

193 Gene expression profiling from blood samples not related with the immune system, includ

194 further explore this relationship, 22 human blood samples obtained from 17 healthy volunteers were a

195 studied prospectively on 10,240 CTCs in 367 blood samples obtained from 294 patients with progressin

196 We screened portal blood samples obtained from 67 human liver transplant re

197 1 treatment, we analyzed paired biopsies and blood samples obtained from NIVAHL patients before and d

198 extracted directly from unprocessed clinical blood samples obtained from patients with P. malariae-mo

199 not been previously detected on a peripheral blood sample of maternal DNA.

200 50 K DNA-methylation array was used on whole blood samples of 340 Ghanaian adults residing in three E

201 med single-cell RNA sequencing in peripheral blood samples of 5 healthy donors and 13 patients with C

202 Methods: Blood samples of 6 patients undergoing (177)Lu-DOTATATE

203 MDSCs), and Lox-1(+) PMN-MDSCs in peripheral blood samples of 62 NSCLC patients before and after nivo

204 Blood samples of a small cohort of patients with cancer

205 Viral RNA was not detected by PCR in whole blood samples of females from any intravaginal experimen

206 and the obtained data were compared with the blood samples of healthy controls (n = 24) and patients

207 n concentration (Hb) in capillary and venous blood samples of HIV-negative and HIV-positive subjects.

208 equency (<0.01%) mutant alleles (~1 copy) in blood samples of pancreatic cancer patients.

209 was further validated by isolating CTCs from blood samples of patients with metastatic pancreatic can

210 andidate lncRNAs differentially expressed in blood samples of the PTB and healthy control groups were

211 circulating tumor cells (CTCs), derived from blood samples of women with advanced breast cancer and d

212 d 2 and provided a pre-dose pharmacokinetics blood sample on day 1 of cycle 3.

213 Using multiple pre-disease peripheral blood samples on the Illumina 450 K and EPIC platforms,

214 ic device (PepS) automating and accelerating blood sample preparation for bottom-up MS-based proteomi

215 n curve of butyrylcholinesterase obtained in blood sample provided linearity between 2 and 12 U/mL, w

216 The blood sample revealed a slight increase in his hemoglobi

217 Quantitative analysis of mRNA expression in blood samples revealed selective overexpression of CNRIP

218 dependent laboratories based on conventional blood samples revealing 96.9% specificity and 97.4% sens

219 the determination of (S)-thalidomide in the blood samples, so it can be successfully used in the ana

220 ies greater than 93% after processing 7.5 mL blood samples spiked with 100 cancer cells.

221 ceptor (AR) point mutation T878A from 7.5 mL blood samples spiked with 50 LNCaP cells using RT-PCR an

222 CCR3pos) as outcome was performed with whole blood samples stimulated with allergen extracts of each

223 g mutations in the same driver genes, serial blood samples taken 4 to 5 years apart showed substantia

224 ted psychosocial questionnaires and provided blood samples that were used to assess inflammatory cyto

225 Weekly blood samples through 100 days in the PET group were tes

226 ld be complementary to the use of peripheral blood samples to allow for a comprehensive understanding

227 volume-controlled (40 muL) paired DBS-whole blood samples to develop an analytical method that invol

228 -oriented antibodies was premixed into whole blood samples to interact with lymphoma cancer cell rece

229 amide) PET scans were acquired with arterial blood sampling to estimate the metabolite-corrected inpu

230 tive UC from active CD in colonic mucosa and blood samples; top discriminating features included many

231 4% reported consistent screening for STIs by blood sample, urine sample or urethral swab, rectal swab

232 emaPEN showed to be robust to the effects of blood sample volume, device lot, analytical operator, an

233 In the morning, a fasting blood sample was taken, and whole-blood platelet aggrega

234 thin 2 weeks after provision of clean water, blood sampling was performed in all 26 airport employees

235 namic tumor uptake data with online arterial blood sampling was performed.

236 PCR detection attempted in 7,716 blood samples, was negative in all 1,312 aerobic bottles

237 Using donor blood samples, we show that red cells heterozygous for P

238 Peripheral blood samples were also sent to a commercial laboratory

239 Whole blood samples were analysed by real-time PCR for Borreli

240 d for fat accumulation and inflammation, and blood samples were analyzed for cholesterol and glucose

241 Peripheral venous blood samples were analyzed including assessments of ser

242 Both venous and capillary blood samples were analyzed using the BD FACSPresto syst

243 ed fifteen patients were enrolled, and 1,006 blood samples were analyzed.

244 Arterial blood samples were collected as a reference standard rep

245 Arterial blood samples were collected as the reference standard (

246 Stool and blood samples were collected at baseline and end of tria

247 Blood samples were collected at different time points an

248 tocols, arterial and internal jugular venous blood samples were collected at rest and coupled with vo

249 Blood samples were collected before treatment (-24 h, -2

250 During stimulation feeding, blood samples were collected daily to determine if infec

251 Blood samples were collected for 96 h after dosing.

252 Serial blood samples were collected for biomarker analysis.

253 asis during a 20-day experimental period and blood samples were collected for hemogram determination

254 Patients' blood samples were collected for quantification of serum

255 e performed to investigate transmission, and blood samples were collected for rapid diagnostic testin

256 Blood samples were collected for serum haptoglobin and a

257 Repeated blood samples were collected from 44 participants 6 mont

258 Peripheral blood samples were collected from healthy women (n = 14)

259 Fingerstick whole-blood samples were collected from participants in an obs

260 A total of 300 blood samples were collected from several health centres

261 Blood samples were collected from the jugular-vein cathe

262 Skin biopsy specimens and blood samples were collected on days 0, 4, 14, 42, and 8

263 2 through day 4 at 2-hour intervals, and 34 blood samples were collected over 21 days from each part

264 Blood samples were collected pre and at 21 days and 3, 6

265 Blood samples were collected to determine plasma and met

266 Blood samples were collected to monitor the development

267 Serial venous blood samples were drawn from 1 to 240 min after intrave

268 Blood samples were drawn, on average, about 3 hours afte

269 Arterial and hepatic venous blood samples were obtained after an overnight fast and

270 Venous blood samples were obtained at 8 time points over an 8-h

271 al crevicular fluid, subgingival plaque, and blood samples were obtained at the same time points.

272 Five blood samples were obtained during the day - at fasting

273 Methods: Venous blood samples were obtained from 48 patients subjected t

274 Skin and blood samples were obtained from 61 patients with AD (20

275 Serially collected blood samples were obtained from men who have sex with m

276 Clinical history, spirometry and blood samples were obtained from pigeon fanciers, 20 wit

277 igher mean body mass index than adults whose blood samples were positive for tTGA at both time points

278 Blood samples were quantified for biomarkers of trihalom

279 Blood samples were retrieved for CYP2D6 genotyping and e

280 Blood samples were screened by specific PCR assays for t

281 Blood samples were screened for known FTD genes.

282 Fasting blood samples were taken at the beginning and end of eac

283 Saliva and blood samples were taken at the end of each treatment to

284 Blood samples were taken every 6 months to measure serol

285 After full-night sleep study blood samples were taken for HMW-HA and HYAL-1 measureme

286 the air-lifted platform for 2 h per day and blood samples were taken periodically to measure variati

287 Blood samples were taken with (RIPC) and without RIPC (C

288 Clinical data was recorded and blood samples were tested for 31 biomarkers.

289 All blood samples were tested for hepatitis B and C markers

290 rom different socioeconomic backgrounds, and blood samples were then collected to measure the level o

291 Fasting blood samples were used to measure ornithine levels.

292 us arterial and discrete arterial and venous blood sampling were performed to determine a plasma inpu

293 lcholinesterase enzyme were also measured in blood sample with linearity up to respectively 0.5 muM,

294 fy the set of genes overexpressed in patient blood samples with high levels of gametocyte-committed r

295 mutant allele frequency in tissue biopsy and blood samples with low mutant fraction.

296 calculating hematocrit (Hct) values of whole blood samples with nominal content of 28%, 35%, 40%, and

297 Analysis of Salmonella-spiked blood samples with the SP-PCR resulted in a limit of det

298 First, on testing of 2,754 contrived whole blood samples, with or without spiked microorganisms, PC

299 Obtaining a blood sample within 24 h postmortem is mandatory.

300 erica serovar typhimurium and enteritidis in blood samples without culture enrichment.